Evering, Teresa

Publications

Sort by

Co-Author Network

selected publications

Cellular rejuvenation to combat HIV-1-related neurocognitive impairment. Trends in microbiology. 2023 Academic Article GET IT
Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City. Antibiotics (Basel, Switzerland). 2023 Academic Article GET IT
Long COVID After Bamlanivimab Treatment. The Journal of infectious diseases. 2023 Academic Article GET IT
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment. Frontiers in cellular neuroscience. 2023 Academic Article GET IT
Times cited: 1
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Annals of internal medicine. 2023 Academic Article GET IT
Transposable elements and Alzheimer's disease pathogenesis. Trends in neurosciences. 2022 Academic Article GET IT
Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Academic Article GET IT
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Infectious disease clinics of North America. 2022 Review GET IT
Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Staphylococcus Aureus Infection Recurrence: CA-MRSA Project (CAMP2). Progress in community health partnerships : research, education, and action. 2022 Academic Article GET IT
Comparative Effectiveness Study of Home-Based Interventions to Prevent CA-MRSA Infection Recurrence. Antibiotics (Basel, Switzerland). 2021 Academic Article GET IT
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy. 2021 Academic Article GET IT
Times cited: 34
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy. Journal of virology. 2020 Academic Article GET IT
Times cited: 5
Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders. Current HIV/AIDS reports. 2018 Information Resource GET IT
Times cited: 2
Helping Basic Scientists Engage With Community Partners to Enrich and Accelerate Translational Research. Academic medicine : journal of the Association of American Medical Colleges. 2017 Academic Article GET IT
Times cited: 30
Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers. Travel medicine and infectious disease. 2016 Academic Article GET IT
Times cited: 12
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use. The Journal of infectious diseases. 2016 Academic Article GET IT
Times cited: 10
From the Bench to the Barbershop: Community Engagement to Raise Awareness About Community-Acquired Methicillin-Resistant Staphylococcus aureus and Hepatitis C Virus Infection. Progress in community health partnerships : research, education, and action. 2016 Academic Article GET IT
Times cited: 7
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection. AIDS (London, England). 2016 Academic Article GET IT
Times cited: 12
Molecular Types of Methicillin-Resistant Staphylococcus aureus and Methicillin-Sensitive S. aureus Strains Causing Skin and Soft Tissue Infections and Nasal Colonization, Identified in Community Health Centers in New York City. Journal of clinical microbiology. 2015 Academic Article GET IT
Times cited: 28
Recurrent furunculosis caused by a community-acquired Staphylococcus aureus strain belonging to the USA300 clone. Microbial drug resistance (Larchmont, N.Y.). 2015 Academic Article GET IT
Times cited: 10
Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users. Journal of addiction research & therapy. 2015 Academic Article GET IT
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope. Retrovirology. 2014 Academic Article GET IT
Times cited: 18
Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City. Journal of acquired immune deficiency syndromes (1999). 2012 Academic Article GET IT
Times cited: 36
Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. PLoS pathogens. 2012 Academic Article GET IT
Times cited: 97
Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell cycle (Georgetown, Tex.). 2007 Academic Article GET IT
Times cited: 66
The immunology of parasite infections in immunocompromised hosts. Parasite immunology. 2006 Information Resource GET IT
Times cited: 72
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine. Immunology. 2006 Academic Article GET IT
Times cited: 28

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1 awarded by National Institute on Aging Principal Investigator 2021 - 2024
Investigating the Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) for Measures of Cardiovascular Disease Risk and Neurocognitive Impairment in People Living with HIV-1 Principal Investigator 2021 - 2024

Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence awarded by National Institute of Mental Health Co-Investigator 2023 - 2027
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2020 - 2027
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction awarded by National Institute on Aging Co-Investigator 2020 - 2025

REACH: Research Enterprise to Advance a Cure for HIV awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2021 - 2026
The Role of Transposable Elements in Healthy Aging and in Alzheimer''s Disease awarded by National Institute on Aging Co-Principal Investigator 2022 - 2024

Clinical and Translational Science Center - UL1 awarded by National Center for Advancing Translational Sciences Key Personnel 2022 - 2027

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) awarded by National Institute of Allergy & Infectious Diseases Principal Investigator Subaward 2020 - 2027
Single-Cell Analysis of HIV-1 Production and Transmission Principal Investigator Subaward 2021 - 2024

more ...

less ...

Background

education and training

B.A., Cornell University 91
M.S., The Rockefeller University 2010
M.D., Weill Cornell Medical College, Cornell University 1997

Contact

full name

Teresa Evering

primary email

evering@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Teresa Evering Assistant Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage